WallStreetZenWallStreetZen

NASDAQ: FONR
Fonar Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

FONR past earnings growth

How has FONR's earnings growth performed historically?
Company
9.93%
Industry
-7.95%
Market
40.76%
FONR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
FONR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
FONR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

FONR past revenue growth

How has FONR's revenue growth performed historically?
Company
4.37%
Industry
0.71%
Market
14.02%
FONR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FONR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FONR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FONR earnings and revenue history

Current Revenue
$101.3M
Current Earnings
$10.7M
Current Profit Margin
10.6%
FONR's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

FONR Return on Equity

Current Company
6.8%
Current Industry
-53.4%
Current Market
-8.4%
FONR's Return on Equity (6.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FONR announces earnings.

FONR Return on Assets

Current Company
5.4%
Current Industry
6.6%
FONR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FONR Return on Capital Employed

Current Company
8.23%
Current Industry
10.7%
FONR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FONR vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FONR$101.29M$24.26M$10.73M+4.09%-11.74%
SERA$330.00k-$36.59M-$38.06M+130.71%N/A
BDSX$44.03M-$47.74M-$63.35M+86.30%N/A
GTH$94.31M-$101.00M-$117.16M+43.63%N/A
NVTA$481.58M-$1.27B-$1.44B+30.40%N/A
View Top Diagnostic & Research Stocks

Fonar Earnings & Revenue FAQ

What were FONR's earnings last quarter?

On Invalid Date, Fonar (NASDAQ: FONR) reported Q3 2023 earnings per share (EPS) of $0.60, up 106.9% year over year. Total Fonar earnings for the quarter were $3.86 million. In the same quarter last year, Fonar's earnings per share (EPS) was $0.29.

If you're new to stock investing, here's how to buy Fonar stock.

What was FONR's earnings growth in the past year?

As of Q4 2023, Fonar's earnings has grown 9.93% year over year. This is 17.88 percentage points higher than the US Diagnostics & Research industry earnings growth rate of -7.95%. Fonar's earnings in the past year totalled $10.73 million.

What was FONR's revenue last quarter?

On Invalid Date, Fonar (NASDAQ: FONR) reported Q3 2023 revenue of $25.84 million up 11.41% year over year. In the same quarter last year, Fonar's revenue was $23.19 million.

What was FONR's revenue growth in the past year?

As of Q4 2023, Fonar's revenue has grown 4.37% year over year. This is 3.66 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.71%. Fonar's revenue in the past year totalled $101.29 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.